×
To start your customized experience click the start button
Customize ?  
Start
Cancer Types
Quick Links
Award Programs
About Us
Careers
Contact Us
Newsroom
Privacy Policy
Terms & Conditions
 
Twitter
Face Book
YouTube
Instagram
 
 
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2019
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.

Leukemia

Alexandra Guadagno
From Trump’s executive order regarding drug prices to today’s top performers and athletes, here’s what is making headlines in the cancer space this week.
Hairy Cell Leukemia Foundation
The Hairy Cell Leukemia Foundation will host a free patient forum on July 17th with guest speaker Dr. Martin Tallman from Memorial Sloan Kettering Cancer Center. This forum is free and open to the public and will cover a range of issues related to patients’ journey with hairy cell leukemia.
Jessica Skarzynski
Here are the top 5 CURE stories for June 2019.
Alexandra Guadagno
From cancer-sniffing dogs to music therapy for pain, here’s what is making headlines in the cancer space this week.
Following the discussion on Vince Fazio’s treatment journey, Dr. Robert J. Kreitman considers the role of multidisciplinary care in hairy cell leukemia management.
Anna Lambertson and Ken Jensen provide insight on the value of support networks and communication for patients with hairy cell leukemia.
 
Dr. Robert J. Kreitman reflects on Vince’s, and other patients’, response to moxetumomab pasudotox in the setting of hairy cell leukemia.
Given potential side effects, Dr. Robert J. Kreitman reviews the importance of hydration for patients with hairy cell leukemia receiving moxetumomab pasudotox.
Following previous lines of treatment for hairy cell leukemia, Vince Fazio enrolled in a clinical trial for CD22-targeted therapy with moxetumomab pasudotox.
Dr. Robert J. Kreitman asks Vince Fazio about his less than optimal response to chemotherapy and rituximab for hairy cell leukemia.
×
×

Sign In

Not a member? Sign up now!
Continue without login
Continue
×

Sign Up

Patient Caregiver Advocate Other